$4.28
0.47%
Nasdaq, Wed, Apr 02 2025
ISIN
US72940R1023
Symbol
PSTI
Sector
Industry

Pluristem Therapeutics Inc. Target price 2025 - Analyst rating & recommendation

Pluristem Therapeutics Inc. Classifications & Recommendation:

Hold
100%

Pluristem Therapeutics Inc. Price Target

Target Price $24.00
Price $4.28
Potential
Number of Estimates 1
1 Analyst has issued a Pluristem Therapeutics Inc. price target 2026. The average Pluristem Therapeutics Inc. target price is $24.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 0 Analysts recommend Pluristem Therapeutics Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Pluristem Therapeutics Inc. stock has an average upside potential 2026 of . Most analysts recommend the Pluristem Therapeutics Inc. stock at Hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Revenue Million $ 0.33 1.83
13.79% 454.27%

1 Analyst has issued a sales forecast Pluristem Therapeutics Inc. 2025 . The average Pluristem Therapeutics Inc. sales estimate is

$1.8m
Unlock
. This is
168.99% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.8m 168.99%
Unlock
, the lowest is
$1.8m 168.99%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $330k 13.79%
2025
$1.8m 454.27%
Unlock
2026
$6.5m 254.34%
Unlock
2027
$14.3m 120.02%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
EV/Sales 23.42

Based on analysts' sales estimates for 2025, the Pluristem Therapeutics Inc. stock is valued at an EV/Sales of

23.42
Unlock
and an P/S ratio of
16.40
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 63.00 35.42%
2025
23.42 62.82%
Unlock
2026
6.61 71.78%
Unlock
2027
3.00 54.55%
Unlock

P/S ratio

Current 44.12 52.49%
2025
16.40 62.82%
Unlock
2026
4.63 71.78%
Unlock
2027
2.10 54.55%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today